CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.
about
Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryNew challenges in therapeutic vaccines against HIV infection.On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection.Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.Virus-Host Gene Interactions Define HIV-1 Disease Progression.Tackling HIV and AIDS: contributions by non-human primate models.T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USA.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay.Wake me up before you go: A strategy to reduce the latent HIV reservoir.A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study.Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.Recent progress in understanding HIV reservoirs.ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir.Immune Interventions to Eliminate the HIV Reservoir.Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection.The B-Cell Follicle in HIV Infection: Barrier to a Cure.Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA.The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8+ Cells.Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.Short-term pIFN-α2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.Tfh1 Cells in Germinal Centers During Chronic HIV/SIV Infection.Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection.Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and PathogenHIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsCD8+ lymphocyte control of SIV infection during antiretroviral therapyPhenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute InfectionCombination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
P2860
Q33742139-2C4AA70F-34B4-4A0B-A7F8-11C9E63BD181Q38692205-8157E6C3-AA19-4156-82E6-330BEF19A753Q38692324-09E24A06-39CE-4485-BEE2-0344AD4AA0F7Q38839394-53C6C933-3D67-4C80-9D75-1370229430E0Q39315707-78F197D6-55C1-4EDF-AD6C-C0DD7B7E968BQ39362365-8E8DAD56-95F9-4991-931B-FC3556D43570Q39400038-1779AEF8-76AF-4EFE-81E2-4904221DE265Q40191155-0F40786F-4716-437E-9D82-10C60DF9D268Q41933638-BCC6BDB2-7A5E-4FC8-B80D-66237A7A9B6DQ42318283-D55FF525-E441-4164-A0B6-3C5732D9F0E6Q45326424-CD4B26BD-C60E-46A0-ABE8-3107F0C9458CQ45349979-D3116F19-D14C-4394-967D-D6BAC5E88DEEQ45874441-6DB1DB22-183F-43B9-ADD9-2F82499D2CD1Q47096232-604ED681-D7AA-4D87-A87D-3E0103E2A05BQ47550536-D47AB5F0-E130-4E61-BD9B-5298D3025553Q47566696-CCCF3AC7-B228-4BA9-9D51-BFF08B6BCE1EQ47585968-38B336BA-8880-4AD4-B26B-32A1C0D96927Q47600020-D9F4CFE7-32C8-4478-9356-82023D01E713Q47600062-61B1583F-B232-4F84-990A-417603C05465Q48204920-31303C7D-5E15-404C-BDB2-F7581B1F92DFQ48505361-9A74D1ED-0316-4BE6-A36E-4F4165F6FF07Q52571192-277F5406-B9F4-470E-9F1A-CD06102BA363Q52593219-44A335EB-82C7-464A-A944-E2A3EA17AF7EQ52680808-D72117DD-7893-4449-A5A1-18A8EF4C41E1Q54222562-0581EE02-8190-45C3-8015-7FBA354F135AQ54942553-27ED81F9-6FAB-4567-8689-70F5EDA925FEQ55048177-172B5F9B-DEFD-4D53-BC84-74ACE30C4F85Q55187093-8002ABEA-F6CF-4F22-814F-5085415B9272Q55365295-2206C2AD-D47A-4497-829A-C053D7754D84Q56918262-349AB818-36C5-4433-B009-1071A51CD94EQ57039737-56B270B1-62E8-44B9-9C44-8E2EE36226E1Q57281967-B10963BA-711F-42E4-9A39-B82F52190098Q58572549-71A5C3D7-A2BD-4296-8B2D-571833B36563Q59125545-60D8A87F-E497-48E3-8C5F-5E7E363E52F6
P2860
CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CD8(+) Lymphocytes Are Require ...... t-Term Antiretroviral Therapy.
@en
type
label
CD8(+) Lymphocytes Are Require ...... t-Term Antiretroviral Therapy.
@en
prefLabel
CD8(+) Lymphocytes Are Require ...... t-Term Antiretroviral Therapy.
@en
P2093
P2860
P1433
P1476
CD8(+) Lymphocytes Are Require ...... rt-Term Antiretroviral Therapy
@en
P2093
Ann Chahroudi
Benton O Lawson
Cynthia A Derdeyn
Emily K Cartwright
Guido Silvestri
Jacob D Estes
Jeffrey D Lifson
Lori Spicer
Melon Nega
P2860
P304
P356
10.1016/J.IMMUNI.2016.08.018
P407
P577
2016-09-01T00:00:00Z